Here are the 10-Q quarterly reports from Clene Inc. Warrant (CLNNW) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow CLNNW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CLNNW filings page.
Clene Inc. reported a net loss of $8.1 million for the quarter ended March 31, 2026, compared with $0.8 million a year earlier. Revenue was minimal at $15,000, down from $81,000, reflecting its early-stage status.
Operating loss improved to $2.1 million from $4.1 million as research and development and general and administrative expenses fell sharply, but large non-cash items, including a $4.6 million loss on the initial issuance of equity and higher warrant-related charges, drove the larger bottom-line loss.
Cash and cash equivalents were $5.9 million as of March 31, 2026, with net cash used in operating activities of $4.5 million in the quarter. Total liabilities of $40.5 million exceeded total assets of $21.7 million, resulting in a stockholders’ deficit of $18.8 million. The company discloses substantial doubt about its ability to continue as a going concern within 12 months without additional financing, despite raising $6.0 million during the quarter and $7.0 million shortly thereafter through registered direct equity offerings.